Orforglipron availability Orforglipron is not yet FDA-approved
PubMed: 35624890Clinical (RCT / meta-analysis) ref-7.Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI N-acetyl cysteine as a glutathione precursor for schizophrenia -- a double-blind, randomized, placebo-controlled trial
Adding glucagon receptor activation targets energy expenditure pathways alongside the appetite and glucose regulation of GLP-1 and GIP
FSA and HSA accepted
Peptide Cy (RL-QN15) accelerates hair regeneration in diabetic mice by binding to the Frizzled-7 receptor
59 These findings suggest that vesicle-mediated signaling may either amplify or restrain ferroptosis depending on cargo composition and uptake efficiency, highlighting extracellular vesicles as bidirectional regulators of ferroptotic susceptibility rather than unidirectional death signals